Moore David Scott 4
4 · Corvus Pharmaceuticals, Inc. · Filed Oct 6, 2025
Insider Transaction Report
Form 4
Moore David Scott
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-10-02+30,000→ 30,000 totalExercise: $7.04Exp: 2035-10-02→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]The underlying shares subject to the option vest and become exercisable as to one-third (1/3rd) of the shares subject to the option on each annual anniversary measured from October 2, 2025, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.